- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
WORLD
8:01pm
From
TECHNOLOGY
5:52pm
Winners of life science prize revealed
Silicon Valley billionaires pledge $50m
- US homebuilder confidence dips in February
- Martin Ruhs and Philip Martin US should copy UK
©AFP/Getty Images
Feb 19, 2013
Novartis scraps chairman’s $78m payout
Shareholder anger forces U-turn on Vasella
- Analysis Novartis pay criticism unlikely to abate
- John Gapper The flaw in paying for executive loyalty
©Reuters
Feb 18, 2013
Novartis chairman’s pay-off sparks anger
Vasella to be given SFr72m ‘golden goodbye’ for confidentiality
From
WORLD
Feb 18, 2013
Suffering side-effects of health reform
Critics see threat to Obamacare goals
From
LEX
Feb 18, 2013
Novartis: Vasella-tions
Swiss drugs group’s chairman should not have accepted $78m payment
Feb 15, 2013
Icahn steps up Herbalife fight with Ackman
Activist investor lifts pressure by building a 13% stake
From
HEALTH CARE
Feb 14, 2013
Cardinal in $2bn AssuraMed home care deal
Remote care increasingly important due to Obama incentives
From
TECHNOLOGY
Feb 14, 2013
Fish threatened by exposure to tranquilliser
Swedish study raises alarm over ecological effects of medicines
Feb 12, 2013
FDA rejects Novo Nordisk insulin remedy
Shares in Danish drugmaker fall 13% after setback
From
LEX
Feb 11, 2013
Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling
From
WORLD
Feb 8, 2013
DNA testers latch on to scandal
Full tests cost £300 and can check for only one species
From
HEALTH CARE
Feb 7, 2013
S&N solid finish outweighs weaker outlook
Good news on knee implants and wound management buoy Smith & Nephew
Multimedia
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
business blog
Novartis did right by scrapping its $78m loyalty payment to outgoing chief Daniel Vasella
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
New Business Developer - Institutional Investors Sales
Wood Mackenzie
-
Chief Competition Economist
European Commission
-
Chief Executive, Shareholder Executive
BIS
-
VP EUROPEAN SALES
Manufacturing
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Novartis pay criticism unlikely to abate
The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack